These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14263453)

  • 1. ALTERATION IN VIRULENCE OF RIFT VALLEY FEVER VIRUS DURING SERIAL PASSAGE IN LAMB TESTIS CELLS.
    COACKLEY W
    J Pathol Bacteriol; 1965 Jan; 89():123-31. PubMed ID: 14263453
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF RECENTLY ISOLATED STRAINS OF RIFT VALLEY FEVER VIRUS ON LAMB TESTIS CELL CULTURES.
    COACKLEY W
    J Pathol Bacteriol; 1963 Oct; 86():530-2. PubMed ID: 14068962
    [No Abstract]   [Full Text] [Related]  

  • 3. PROTECTION OF MICE AND LAMBS AGAINST PANTROPIC RIFT VALLEY FEVER VIRUS, USING IMMUNE SERUM.
    BENNETT DG; GLOCK RD; GERONE PJ
    Am J Vet Res; 1965 Jan; 26():57-61. PubMed ID: 14269221
    [No Abstract]   [Full Text] [Related]  

  • 4. TITRATION OF RIFT VALLEY FEVER VIRUS IN HAMSTER KIDNEY CELLS IN THE ABSENCE OF SERUM.
    BOYLE JJ
    Am J Vet Res; 1965 Jan; 26():190-1. PubMed ID: 14266928
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial cultures of lamb testicular cells and their use in virus studies.
    HESS WR; MAY HJ; PATTY RE
    Am J Vet Res; 1963 Jan; 24():59-64. PubMed ID: 13954242
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection of avirulent variants of Rift Valley fever virus.
    Koyama H; Higashihara M
    Kitasato Arch Exp Med; 1974 Dec; 47(4):67-76. PubMed ID: 4465474
    [No Abstract]   [Full Text] [Related]  

  • 7. A SLOWLY SEDIMENTING INFECTIOUS COMPONENT OF RIFT VALLEY FEVER VIRUS.
    POLSON A; LEVITT J
    J Hyg (Lond); 1963 Dec; 61(4):451-69. PubMed ID: 14099024
    [No Abstract]   [Full Text] [Related]  

  • 8. An inactivated rift valley fever vaccine.
    Barnard BJ; Botha MJ
    J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SEROLOGICAL PROPERTIES AND PATHOGENICITY OF THE R-VIRUS IN SUCKLING MICE].
    DREIZIN RS; ZUBOVA ZF; IAVOROVSKAIA VE; BOCHAROV EF; FOKINA GI; BALANDINA AM; ROZINA EE; VOROBEVA NN; ZALESSKII GD; ZHDANOV VM
    Vopr Virusol; 1964; 30():462-8. PubMed ID: 14271696
    [No Abstract]   [Full Text] [Related]  

  • 10. An epidemic of Rift Valley fever in Egypt. 2. Isolation of the virus from animals.
    Imam IZ; El-Karamany R; Darwish MA
    Bull World Health Organ; 1979; 57(3):441-3. PubMed ID: 314355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.
    Wilson WC; Davis AS; Gaudreault NN; Faburay B; Trujillo JD; Shivanna V; Sunwoo SY; Balogh A; Endalew A; Ma W; Drolet BS; Ruder MG; Morozov I; McVey DS; Richt JA
    Viruses; 2016 May; 8(5):. PubMed ID: 27223298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sheep challenge model for Rift Valley fever.
    Faburay B; Gaudreault NN; Liu Q; Davis AS; Shivanna V; Sunwoo SY; Lang Y; Morozov I; Ruder M; Drolet B; Scott McVey D; Ma W; Wilson W; Richt JA
    Virology; 2016 Feb; 489():128-40. PubMed ID: 26748334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CONTRIBUTION TO THE CULTIVATION IN VITRO OF VACCINIA-VIRUS FOR THE PREVENTION OF VARIOLA.
    FRENKEL HS
    Isr Med J; 1963; 22():433-41. PubMed ID: 14153477
    [No Abstract]   [Full Text] [Related]  

  • 14. Arboviruses pathogenic for domestic and wild animals.
    Hubálek Z; Rudolf I; Nowotny N
    Adv Virus Res; 2014; 89():201-75. PubMed ID: 24751197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
    Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALTERATION OF THE PATHOGENICITY OF SOME GROUP B COXSACKIE VIRUSES UNDER DIFFERENT CONDITIONS OF PASSAGE. I. VIRUS TYPE 4.
    VIZOSO AD; SANDERS FK
    Acta Virol; 1964 Jan; 8():38-45. PubMed ID: 14106020
    [No Abstract]   [Full Text] [Related]  

  • 18. TRANSMISSION OF VIRUS FROM FIELD CASES OF AVIAN LYMPHOMATOSIS. II. DEVELOPMENT OF STRAINS BY SERIAL PASSAGE IN LINE 151 CHICKENS.
    FREDRICKSON TN; BURMESTER BR; OKAZAKI W
    Avian Dis; 1965 Feb; 9(1):82-103. PubMed ID: 14253999
    [No Abstract]   [Full Text] [Related]  

  • 19. PROPAGATION AND CULTURAL CHARACTERISTICS OF TAHYNA VIRUS AND OTHER MEMBERS OF THE CALIFORNIA COMPLEX IN HELA (GEY) CELLS.
    KUNZ C; BUCKLEY SM
    Am J Trop Med Hyg; 1964 Sep; 13():734-7. PubMed ID: 14205895
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a Rift Valley fever virus viremia challenge model in sheep and goats.
    Weingartl HM; Miller M; Nfon C; Wilson WC
    Vaccine; 2014 Apr; 32(20):2337-44. PubMed ID: 24631070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.